Infinity Bio logo

Infinity Bio

Baltimore, MD

Infinity Bio is a Circulating Antibody Repertoire Profiling service company, leveraging a novel technology, MIPSA (Molecular Indexing of Proteins (or Peptides) by Self Assembly) developed by Dr. H. Ben Larman, a pioneer in this field. Our various antigen libraries provide cost effective, comprehensive and quantitative analyses of antibody responses to infections, vaccinations, self-antigens and allergens. Our proprietary method allows for the rapid and flexible content customization. Infinity Bio can design and create customer specific peptide libraries against any target of choice.

infinitybio.com

Company Details

Founded

2023

Employees

Between 20 - 50 employees

Raised

$12,516,093

Headquarters Location

Baltimore, MD

Public

No

Acquired

No

CEO

Caroline PopperCaroline Popper

Founders

Joel Credle
Joel Credle

Company Collections

These are collections Infinity Bio is a part of. Click on the collection name to view similar companies.

Infinity Bio Headquarters Location

6200 Seaforth St, Baltimore, MD 21224

Total Amount Raised: $12,516,093

Infinity Bio Funding Rounds

  • Series A

    $8,000,000

    Series A Investors

    Illumina Ventures
    PTX Capital
    Propel Baltimore Fund
    Blackbird BioVentures
  • Seed

    $4,516,093

Funding info provided by Diffbot.

Infinity Bio Reviews

0 out of 5 stars

Based on 0 reviews

Review data

Share your thoughts

Worked here? Share your experience. Help others decide if this company is right for them. Write a review on Infinity Bio.

Recent reviews